FedCircuitBlog

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights an article summarizing a recent decision in a pharmaceutical case, commentary on a recent opinion addressing a bid challenge, and news concerning FanDuel’s challenge to a patent claiming a remote gambling system.

• Federal Circuit May Have its Eye on West Texas Patent Hot Spot – A Federal Circuit order in In re Adobe Inc. may signal the Court’s attention to a new patent litigation hot spot in Central Texas.
• Federal Circuit Reverses TTAB Ruling on Standing – The Federal Circuit overturns TTAB standing ruling in trademark dispute.
• When “Killing Competition” Isn’t Anticompetitive – Antitrust claims fall flat as the Federal Circuit affirms the lower court’s dismissal of Power Analytics Corp. v. Operation Technology, Inc.

Here’s the latest.

• GI Bill Ruling Won’t Come in Time for Fall Classes – Veteran students deprived of GI Bill benefits needed for the Fall semester while waiting for Federal Circuit input.
• Prior Work Can Lead to Joint Inventorship – Work by co-inventors performed independently and publicly disclosed prior to the conception of the claimed invention can constitute joint inventorship.
• Federal Circuit Won’t Revisit Relistor Ruling – Valeant failed to persuade the Federal Circuit to revisit their obviousness decision in Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc.

Here’s the latest.

• Federal Circuit Won’t Undo Intel Wins – The Federal Circuit upheld PTAB rulings in Intel Corp. v. Alacritech, Inc., cementing victory for Intel and other tech companies.
• Flash-of-Genius as Evidence of Eligibility – Steve Morsa filed a new Supreme Court petition using the Court’s “flash of genius” argument to justify granting certiorari.
• Another Arthrex Petition – Arthrex filed its second petition, out of three total petitions for writ of certiorari, challenging the Federal Circuit’s decision in Arthrex, Inc. v. Smith & Nephew, Inc.

Here’s the latest.

• Federal Circuit Affirms District Court’s Eligibility Analysis – In Packet Intelligence, LLC v. Netscout Systems, Inc., the court held NetScout willfully infringed Packet Intelligence’s patents, rejecting NetScout’s argument that the patents were directed toward an abstract idea.
• Nike and Adidas Escape Patent Claims Over Athletic-Shoe Soles – According to a Federal Circuit decision on July 16, the shoe companies did not infringe Akeva’s wear-reducing patent because the companies’ shoes do not have detachable soles.
• Patent invalidity claim is no cure for ITC’s import ban on grippy mugs – On July 16, the Federal Circuit ruled that a party cannot challenge a general ITC exclusion order barring importation of products for infringing a patent by claiming the patent is invalid.

Here’s the latest.

• U.S. Wrongly Linked 3 Steel Companies In Duty Probe – The U.S. Department of Commerce improperly tied steel companies together in an anti-dumping investigation, said the Federal Circuit.
• All Substantial Rights Deemed Test Informative – With the decision in Immunex Corp. v. Sandoz Inc., the Federal Circuit endorses the “all substantial rights” test for the first time.
• Section 315(a) Calls At Institution Cannot Be Reviewed – Finally, the Federal Circuit applied the recent Supreme Court decision in Thryv, Inc. v. Click-to-Call Techs to a Section 315(a) and (b) case.

Here’s the latest.

• Federal Circuit Denies Uniloc’s Motion to Seal Documents – In Uniloc 2017 LLC v. Apple, Inc., the Federal Circuit affirmed the district court’s no-seal order, with the exception of third party licensees who were promised confidentiality.
• Toyota Fails to Revive Patent on Fingerprint-Reducing Coating – On Friday, the Federal Circuit agreed with PTAB’s conclusion that Toyota’s patent for reducing fingerprints on touchscreens was invalid for obviousness in Toyota Motor Corp. v. Reactive Surfaces Ltd.
• Federal Circuit’s Ruling Could Make it Easier to Prove Infringement of SEPs – In Godo Kaisha IP Bridge I v. TCL Commc’n Tech. Holdings Ltd., the Federal Circuit seemed unconvinced by TCL’s oral argument against the district court’s finding that TCL infringed two IP Bridge patents.

Here’s the latest.

• Federal Circuit Keeps Expanding Appointments Decision – The Arthrex, Inc. v. Smith & Nephew, Inc. decision was broadened to also encompass ex parte appeals according to the Federal Circuit’s precedential ruling in In re Boloro Global Ltd. on Tuesday.
• BofA’s $173M Refund Suit Belongs In Claims Court – The Federal Circuit vacated and remanded Bank of America Corp. v. United States to the Court of Federal claims because the district court lacked standing under Section 1346(a)(1) of the U.S. Judicial Code.
• Fitbit Given Another Shot At Nixing Biometrics Patent – Fitbit, pursuant to the Federal Circuit’s precedential opinion in Fitbit, Inc. v. Valencell, Inc., was granted a second chance to invalidate all of Valencell’s claims because of an erroneous standing ruling by the PTAB.

Here’s the latest.

• Apple loses seven-year import duty legal fight – The Federal Circuit affirmed the U.S. Government’s categorization of Apple’s iPad Smart Covers, thereby subjecting the models to tariffs.
• Federal Circuit Affirmed Win Against Database Platform – Hulu successfully challenged a database patent in Sound View Innovations, LLC v. Hulu, LLC.
• Federal Circuit Vacates Denial of Attorneys’ Fees – In a precedential opinion, the Federal Circuit held that the district court must consider the objective unreasonableness of an infringement claim in determining whether to grant attorneys’ fees.

Here’s the latest.

• Amgen Defeats Appeal Over Arthritis Drug Patents – Amgen successfully defends its multi-billion-dollar arthritis drug patents in the Federal Circuit on Wednesday.
• Federal Circuit Affirms PTAB Ax Of Aircraft Space-Saving IP – The Federal Circuit, in a precedential decision, invalidated two aircraft patents in B/E Aerospace Inc. v. C&D Zodiac Inc.
• No rehearing for Biogen in Tecfidera patent appeal – Biogen was denied an en banc rehearing of Biogen International GmbH v. Banner Life Sciences LLC, finalizing Banner’s win in the Federal Circuit.

Here’s the latest.